Humana AB (publ) (STO:HUM)
Sweden · Delayed Price · Currency is SEK 68.40
+0.10 (0.15%)
Sep 24, 2026, 5:29 PM CET
Humana AB Market Cap
Humana AB has a market cap or net worth of 3.25 billion as of September 24, 2026. Its market cap has increased by 59.84% in one year.
Market Cap
3.25B
Enterprise Value
7.40B
Revenue
10.04B
Ranking
n/a
PE Ratio
18.95
Stock Price
68.40
ChartMarket Cap Chart
Since March 22, 2016, Humana AB's market cap has decreased from 3.40B to 3.25B, a decrease of -4.27%. That is a compound annual growth rate of -0.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 3.25B | 31.04% |
| Dec 30, 2025 | 2.48B | 34.25% |
| Dec 30, 2024 | 1.85B | 37.23% |
| Dec 29, 2023 | 1.35B | -26.88% |
| Dec 30, 2022 | 1.84B | -48.20% |
| Dec 30, 2021 | 3.55B | 18.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 154.37B |
| Getinge AB | 65.59B |
| Sectra AB | 54.49B |
| Medicover AB | 39.36B |
| RaySearch Laboratories AB | 5.85B |
| CellaVision AB | 3.98B |
| Hansa Biopharma AB | 3.68B |
| Egetis Therapeutics AB | 3.53B |